LM Advisors’s Vaxart VXRT Stock Holding History

LM Advisors’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6,225	Closed	-$3.56K	–	691
2023 Q4	$3.56K	Buy	+6,225	New	+$4.3K	﹤0.01%	621

Other funds holding VXRT

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LM Advisors's VXRT Position: Q1 2024 in Review

LM Advisors sold out of Vaxart (VXRT) in Q1 2024, closing a stake of 6,225 shares — an estimated $3.56K sold.

LM Advisors first reported a position in VXRT in Q4 2023 and held it in 1 quarter. The position peaked at $3.56K in Q4 2023. 106 funds tracked by Wall St. Rank hold VXRT as of Q1 2024.

LM Advisors reported no remaining Vaxart position as of Q1 2024 after selling out during the quarter.
LM Advisors sold 6,225 Vaxart shares in Q1 2024, an estimated $3.56K.
LM Advisors first reported a position in Vaxart in Q4 2023 and held it in 1 quarter.
LM Advisors's Vaxart position peaked at $3.56K in Q4 2023.
106 funds tracked by Wall St. Rank held Vaxart as of Q1 2024.

Based on LM Advisors's 13F filing for Q1 2024, filed 15 May 2024.